Featured posts

0 573

Lawmakers are proposing to legalize recreational cannabis in Illinois, however the legislation will most likely not come up for a vote until 2018. Advocates recently introduced proposals that would make it legal for adults 21 and older to grow, buy, and possess limited amounts of cannabis.

Sponsors said the state would license and regulate businesses to grow, process, and sell the plant, and it would establish safety regulations such as testing and labeling requirements. The proposal would also allow residents to possess up to 28 grams of marijuana and to grow five plants. The bills propose taxing cannabis at a rate of $50 per ounce wholesale, plus the state’s standard 6.25% sales tax.

Based on sales of recreational cannabis in Colorado, the Marijuana Policy Project, a national advocacy group, estimates sales in Illinois could generate about $350 million to $700 million per year. Governor Bruce Rauner and House Speaker Michael Madigan reserved judgment, as they typically do with new proposals. However, the Illinois Association of Chiefs of Police opposes legalization, saying cannabis poses a threat to public health and safety, and causes potential enforcement problems because it conflicts with the federal restriction on cannabis.

The co-sponsors, Senator Heather Steans and Representative Kelly Cassidy, both Democrats from Chicago’s North Side, said they do not plan to call the proposal for a vote this session but will hold hearings to get feedback and see whether some version of a legalization proposal can get support next year. Steans said, “If we bring this out in the open, we can generate revenue legally rather than for the black market.”

Cassidy said cannabis prohibition creates far more problems than it prevents. She said, “Regulating marijuana and removing the criminal element from marijuana production and sales will make our communities safer.” Eight states have permitted the sale of the drug, generally by referendum. However, in Illinois, it’s very challenging to get a binding vote on the statewide ballot, so it probably would take legislative action to change the law.

0 466

Recently, Legislature sent separate proposals to the floor pushing for the legalization of commercial hemp production in West Virginia. Often, hemp is associated with marijuana. However, the new legislation declares hemp’s industrial uses. The bills state as long as the crop stays below a 1% threshold of tetrahydrocannabinol, the psychoactive component of cannabis, it can be produced after receiving licensing from the Agriculture Commissioner.

At its meeting Wednesday, the Senate Agriculture Committee sent Senate Resolution 35 up to the chamber floor. That resolution, if passed through the House of Delegates as well, works as a call from the Legislature to the U.S. Congress to distinguish hemp from marijuana by the THC threshold. Senator Robert Beach said commercial hemp means jobs for West Virginia in terms of production, manufacturing it into commercial products, and retail.

As far as its special proximity to cannabis, he said the two crops’ usages show their differences.
He said, “With hemp, the old saying is you could smoke 500 acres of it and it won’t get you high.” According to the resolution, hemp products can be made through the crop’s fiber, seed, seed oil, and floral extracts including paper, fabric, body care products, and essential oils, according to the resolution.

Senator Sue Cline voiced support for the resolution as well. She said Kentucky already has embraced hemp as a cash crop, and it’s time for West Virginia to catch up. Communications director for the West Virginia Department of Agriculture, Crescent Gallagher, said the department fully supports both the Senate resolution and the House proposal. Though the crop’s relationship to cannabis has gummed up similar legislation in the past, he said newfound support could push the proposal through this year.

He said, “The Department fully supports the Senate resolution and House bill. We believe hemp is a niche crop that has the opportunity to bring producers into the state.” Only the Department of Agriculture and colleges and universities authorized by the Agriculture Commissioner can grow hemp in the state under current law.

Following suit with the Senate, the House Judiciary Committee chose to send HB 24 53 to the floor, which gives discretion to the Commissioner of Agriculture to dispense licenses to produce hemp commercially. However, it only allows those licensed through a university to grow hemp for research purposes, not commercial ones.

0 6800

Among the many segments of the marijuana industry that we cover, CBD has taken on a big role not only for its biotech-based applications but also for its uses outside of the health sciences sector. And with the growth that the market as a whole could be set to see, CBD companies are definitely in the spotlight for the foreseeable future.

One Marijuana Stock that we’ve been reporting on since late last year has been Ubiquitech Software Corp (UBQU).  Now don’t let the name fool you, this company, through its subsidiary HempLife Today™ is breaking barriers with its CBD brand while also hitting major milestones over the last year.  What could be best of all is that 2017 could already have the stage set for yet another record setting period in (UBQU)’s company history.

Earlier this morning the company put out preliminary guidance on what it is anticipating to be a banner year ahead.  According to the release, the company anticipates that revenues for the year ending November 30, 2017 will increase over 55% from $3,493,113, which was reported in the annual period ended November 30, 2016 to approximately $5,450,000.

Ubiquitech Gives Fiscal Year 2017 Revenue Guidance; Anticipates 55% Year Over Year Increase To $5,450,000

“We are very pleased with the progress we have made and we will continue to do everything within our power to keep our company relevant and growing” said James Ballas, CEO “With the quality of our products, our marketing, customer support and satisfaction, and our dynamic thinking, we will continue this growth through 2017 and into 2018, which we are already planning big things for, and this is the thinking that will take our revenues to even higher gains as we continue. It’s a very exciting industry and we don’t plan to stop until the CannazALL brand is a household word.”

(UBQU) is no stranger to growth.  If you’re just pulling up the company’s other headlines, you’ll already notice major strides being made on the product end. Toward the beginning of the year, the company announced that it had concluded negotiations and reached an agreement to expand its hemp growing capabilities through an additional 140 acres of available hemp operations. They’ve also expanded their current product line to include brand new offerings.

But back to growth…Had this been a random company with its first press release in history, we might be a bit skeptical but (UBQU) has already proven its ability to run a multi-million dollar business that has managed to grow significantly just within the last year alone. On top of bullish guidance for the year ahead, (UBQU) is also coming off of a strong year and noticeable earnings growth.

Revenues for the last quarter increased to $1,225,015 and to $3,493,113 for the year. But what’s more is that net income increased over 700% from the previous year to $334,350 from $39,651 in 2015. First quarter guidance has already come in bullish on its own with the company expecting revenues for the quarter ended February 28, 2017 to increase over 50% from $697,640 in the first quarter of last year to approximately $1,050,000.

Of course this is just initial guidance and with the year ahead, nothing is set in stone. But one thing is certain and that based on the last releases from the company, (UBQU) has set itself on a growth trend.  So this bullish guidance could be shedding some light on what’s to come for this company in the very near term.

The opportunity for taking advantage of the growth that CBD is beginning to see, could be important to take into consideration.  We’ve previously written about this market and how it could be on a path for growth.  Figures estimate that the CBD market will grow to a $2.1 billion market in sales by 2020. That’s a 700% increase from 2016.  Think about this for a moment: (UBQU) is already growing and is expecting to continue this growth to the tune of 50+% for the year according to today’s announcement…this is all going to happen during a time where the CBD industry as a whole is also anticipating significant growth. Having already come off of a banner year, we think that preliminary guidance from the company would suggest that this is something to be paying close attention to moving into the coming weeks/months/quarters.

Again, you can access today’s (UBQU) news here:

Ubiquitech Gives Fiscal Year 2017 Revenue Guidance; Anticipates 55% Year Over Year Increase To $5,450,000

Pursuant to an agreement between MAPH and Ubiquitech Software Corp., we were hired for a period beginning November 11 2016 and ending May 11, 2017 to publicly disseminate information about (UBQU) including on the Website and other media including Facebook and Twitter. We are being paid $0 (CASH) for or were paid “10 million” shares of restricted common shares. We may buy or sell additional shares of (UBQU) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Full Disclaimer Here




0 2711

Today was a busy day for cannabis stocks and this is important as it follows a couple rough weeks of trading.

Some of the important develops we think investors should take note of, include:

1. MassRoots, Inc. (MSRT) announced that Google Play approved its mobile application for distribution to Android devices. In early November, MassRoots was removed from Google Play due to a compliance review.
2. Emblem Corp (EMC.V) (EMMBF) had its Speculative Buy rating and $3.75 price target reaffirmed by Canaccord Genuity. The report said:
3. CanniMed Therapeutics (CMED.TO: TSX) announced the receipt of its first two Health Canada issued export permits for medical cannabis oils. In addition, CanniMed received initial purchase orders for all three CanniMed Oils for distribution to both Australia and the Cayman Islands for pharmacy dispensing. These two Health Canada-issued export permits will include all three oil products. By June 30th, CanniMed will have shipped 3,600 ml and 12,960 ml of CanniMed Oils to Australia and the Cayman Islands respectively. The company expects to provide additional details with respect to these developing opportunities within the coming weeks.
4. Golden Leaf Holdings Ltd. (GLDFF) signed a binding Letter of Agreement to acquire Chalice, a vertically integrated Oregon based cannabis company. In conjunction with the transaction, Golden Leaf entered into an engagement agreement with Canaccord Genuity with respect to a best efforts brokered private placement. The company plans to sell approx. $35 million worth of subscription receipts and the net proceeds will be used to satisfy the cash component of the purchase price for the Chalice Farms and to fund the company.
5. Future Farm Technologies’ (FFRMF) (FFT.CN) majority owned subsidiary, FFM Consulting Services purchased an extraction machine for the manufacture of concentrated cannabis oil and purified distillate. The equipment is estimated to be delivered, installed and in full production within the next 90 days.
6. American Cannabis (AMMJ) announced that five of its active clients have successfully submitted applications for acquiring business licenses to operate within Pennsylvania’s medical cannabis program. Two clients have applied for licenses to legally dispense, one applied for a license to legally cultivate, and two clients have applied to do both.
7. NEMUS Bioscience, Inc. (NMUS) and the University of Mississippi announced that bactericidal synergy was achieved against multiple species of MRSA utilizing a proprietary cannabinoid-based therapeutic platform.

Pursuant to an agreement between MAPH and Future Farm Inc., we were hired for a period of 30 days to publicly disseminate information about (FFRMF) including on the Website and other media including Facebook and Twitter. We are being paid $37,500 (CASH) for and were paid 1 million shares of restricted common shares. We may buy or sell additional shares of (FFRMF) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. An affiliate of MAPH Enterprises LLC owns 43,500 shares of EMBLEM as well as 21,750 Warrants


0 694
Florida Marijuana

A proposal that would award $2.5 million for UF to study medical marijuana recently moved forward in the Florida House of Representatives. The proposal states that money from the General Revenue Fund will be used to fund UF’s study on the safety and efficiency of medical cannabis. The bill, which passed through the Health Care Appropriations Subcommittee, moved into the Appropriations Committee on Friday.

If the bill is passed in the committee, it will go to a full House vote for final approval. If it passes through the House, the proposal states the one time fund will be finalized in July. House member Dane Eagle, a republican who represents District 77, sponsored the proposal, which was first submitted February 7. Janine Sikes, spokesperson for UF, wrote in an email that the money would fund UF’s proposed Cannabis and Safety Outcomes Surveillance System, a program which would monitor the safety and effectiveness of medical cannabis on 25,000 enrolled patients throughout the state.

Florida’s Amendment 2, a constitutional amendment that allows stronger cannabis to be used for a broader list of conditions, took effect in January. Of the six medical cannabis dispensaries licensed in Florida, two are in Alachua County, according to the Florida Department of Health’s Office of Compassionate Use. Sikes said the UF program would monitor treatments that haven’t been approved by the FDA. UF would create a secure Data Warehouse to track patient data as part of the program.

She said the $2.5 million would be for costs such as faculty salaries and data processing. She stated, “Evidence is lacking to evaluate risk/benefit of medical marijuana. It is pivotal that the state establishes a system to monitor emerging safety concerns, especially for use in children.” She said the proposal is related to the Compassionate Medical Cannabis Act of 2014, which requires physicians to submit a quarterly patient treatment plan to the UF’s College of Pharmacy for research on the safety and effectiveness of low-THC cannabis on patients. The details of the proposal state that it would offer funding to implement research provisions in the 2014 act.

A UF nursing senior, Alicia Ciliezar, said she supports the use and research of medical cannabis. The substance helps improve pain levels for individuals with issues such as neurologic conditions and digestive disorders. She said, “I’m very eager to see the aims of the study, the objectives and the outcomes. I’m sure it will be fascinating and shape our perception on the substance.”

0 756

Although the benefits associated with hemp are endless, researchers have been unable to learn all the benefits associated with it. While significant progress has been made over the last few years, we still have a lot to learn.

This lack of knowledge is not the result of inadequate technology or resources. It is the result of inadequate government policy. Growing hemp has been illegal for almost a century which prevented researchers from being able to learn about the benefits associated with it.

The Next Trillion-Dollar Industry

In 1916 the chief scientists at the Department of Agriculture, created paper from the inner portion of the hemp stem. The paper was said to be better than paper made from pulp wood however, these findings were never confirmed due to the misconception that hemp could get you high.

Industrial hemp and marijuana are two completely different plants, inside and out. Hemp contains a very small amount (less than 1%) of tetrahydrocannabinol (THC), the primary psychoactive ingredient in marijuana (the chemical that gets a user high).

In 1938, when Popular Mechanics said hemp was a billion-dollar product, they did not even know 20% of the uses associated with hemp. While it is impossible to quantify the newly discovered benefits of hemp, it is possible to determine that $1 billion in 1938 is a much a larger sum of money today.

An Industrial Hemp Revolution

The cannabis industry continues to be the fastest growing industry in the world and many companies working to capitalize on opportunities within this emerging market.

Several products which are used by people every day can be created from hemp. These include paper, clothing, building materials, fuel, and nutrition. Despite industrial hemp’s known benefits, the Federal government has continued to push back on what may one day be a $1 trillion industry.

Hemp Inc. (HEMP) is a company levered to the industrial hemp industry that we have been watching closely. The company was the first business to register with the North Carolina’s hemp commission as a hemp processor and a farm aggregator.

Hemp currently has contracts with 32 farmers and has the first hemp food processing plant that been permitted in North Carolina. The plant is under construction and is expected to start being able to process hemp seed into food later this year (expected to process CBD as well).

A Premier Cultivator and Educator

Not only is Hemp poised to be one of the largest industrial hemp producers in the world, it will also be one of the largest educators.

On Saturday, the company produced the first Hemp University educational symposium. The seminar provided important information and insight when it comes to the history and future of the hemp industry. It also helped teach farmers how to grow, sell and profit from industrial hemp through real world examples.

The seminar featured world renown industry experts from all over the country. From New York to Oregon, from Virginia to Nevada, attendees received in-depth insight and education from several industry leaders.

What is The Hemp University?

The Hemp University was established with the goal to educate its attendees on key topics such as transitioning from traditional farming to organic farming, different hemp cultivar strains, how and where to get certified seeds, planting and harvesting industrial hemp, an in-depth history of hemp and its many uses, agronomy, permaculture, ecological advantages and many more courses as the curriculum is expanded.

Monthly classes will also cover such topics as organic certification, potential licensing fees, what’s happening with industrial hemp in different states around America, high CBD strains and different CBD extraction technologies and marketability of the crop.

Hemp products will continue to be showcased these seminars and anyone interested in attending or speaking at future events should visit www.thehempuniversity.com

MAPH owns “6 million” shares of restricted common shares of Hemp, Inc.  PLEASE READ OUR FULL PRIVACY POLICY & TERMS OF USE & DISCLAIMER

0 850

Senate Bill 329, introduced by Sen. Tick Segerblom, D-Las Vegas, would loosen some medical marijuana regulations, an idea Governor Brian Sandoval has stated his opposition to. Senate Bill 329 proposes a plethora of changes to how the state deals with cannabis. It would allow veterans to obtain a medical marijuana card, add PTSD to the list of conditions that qualify for those cards and even make it so cards do not need to be renewed. Medical cards now last 12 months in Nevada.

The vast majority of cardholders in Nevada can only grow medical cannabis if they live more than 25 miles from a dispensary. The proposal would lift that halo, and allow all cardholders to grow, cultivate, and produce cannabis products. However, the bill could face resistance, even if it passes both the Senate and Assembly. At the first meeting of the state’s cannabis task force, Sandoval’s legal counsel, Dan Stewart, stated the governor is “not interested in action that would water down our current medicinal marijuana laws and regulations.” If the proposal made it Sandoval’s desk and he chose to veto it, a two-thirds vote in both houses would be needed for an override.

SB 329 also calls for several other changes, including:

Setting the foundation for state universities to begin researching the effects of marijuana.
transferring the state’s medical marijuana program from it’s housing under the Division of Public and Behavioral Health to the Department of Taxation, which is also tasked with creating and enforcing regulations for recreational marijuana.

authorizing “nonprofit medical marijuana dispensaries,” which would be able accept donated marijuana which it could sell for a reduced price to patients based on financial need.
requiring medical marijuana businesses to install security cameras which police can access in real time.
allowing for the cultivation and production of hemp in Nevada

0 760

Supervisor Jeff Sheehy, who Mayor Ed Lee appointed to the District 8 post in January, introduced legislation last week that would create a seven-member Cannabis Commission and Cannabis Department with a director and staff in San Francisco. The commission will decide whether to grant or deny permits related to commercial cannabis businesses as well as decide whether to suspend such permits based on yet-to-be-developed guidelines. San Francisco is currently working on regulations for the recreational cannabis industry after California voters legalized the substance by passing Proposition 64 back in November.

The state is expected to begin issuing licenses for recreational cannabis as early as January 2018, but operations must comply with local laws. Sheehy’s bill gives the mayor the power to appoint a director of the Cannabis Department and grants the mayor the power to appoint all seven commissioners. Bill Barnes, Sheehy’s legislative aide, said that under the city charter a commission created by an ordinance must have all appointments made by the mayor. Splitting them up between the mayor and the Board of Supervisors would require approval from voters.

He likened the Cannabis Commission to the Entertainment Commission, which was first created through an ordinance in 2002 by then-Supervisor Mark Leno. The commission appointments to the Entertainment Commission were initially made by the mayor under the ordinance, but subsequently divided between the board and mayor by voter approval of Proposition F, also in 2002. Barnes pointed out that the mayoral Cannabis Commission appointees would require approval by the board. It is a high threshold, however. To reject mayoral appointees would take a two-thirds board vote. Supervisor Hillary Ronen said she supports the creation of the department, but had yet to review the proposal. She said she “absolutely” preferred split appointments on the commission. The first opportunity to ask voters to split up appointment power on a cannabis commission would be at the next scheduled election in June 2018.

Some of the most significant city commissions have appointments split between the mayor and the Board of Supervisors, such as the Planning Commission and Police Commission. Supporters of split appointments argue it creates a better balance of power between the two branches of government and better representation of neighborhood concerns. As The City faces budget cuts and other financial uncertainty from possible federal cuts under President Donald Trump, costs of creating the department would likely be a concern. Barnes, however, said that Sheehy doesn’t want any general fund dollars funding the department. Barnes stated, “It will be a fee-based department.” That means the marijuana industry will fund the department’s staffing costs through permit and license fees, rather than the regular taxpayer.

0 654

MassRoots Approved for Google Play

“Re-gaining MassRoots’ listing on Google Play is a significant milestone that enables distribution to the millions of medical cannabis consumers that own Android devices,” stated MassRoots Chairman and CEO Mr. Isaac Dietrich. “MassRoots is already one of the most popular consumer platforms available, as evidenced by us recently announcing our 1 millionth registered user. I am confident that with this barrier to growth eliminated and several soon-to-be announced initiatives, we will be able to significantly leverage the 4/20 holiday season. We look forward to continuing to expand our market share of cannabis consumers and dispensaries to further drive shareholder value.”

About MassRoots

MassRoots is one of the largest technology platforms for the regulated cannabis industry. The Company’s mobile apps enable consumers to make educated cannabis purchasing decisions through community-driven reviews. MassRoots is proud to be affiliated with the leading businesses and organizations in the cannabis industry, including the ArcView Group and National Cannabis Industry Association. For more information, please visit MassRoots.com/Investors.

Forward-looking Statements

Certain matters discussed in this announcement contain statements, estimates and projections about the growth of MassRoots’ business, potential partnerships, new features, and related business strategy. Such statements, estimates and projections may constitute forward-looking statements within the meaning of the federal securities laws. Factors or events that could cause our actual results to differ may emerge from time to time. MassRoots undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The recipient of this information is cautioned not to place undue reliance on forward-looking statements.

0 3673
Marijuana Stocks

Marijuana Stocks, especially Cannabis Companies with strong ties to Biotech have been increasingly front and center on Wall Street’s main stage.  Marijuana Stocks and the Cannabis-Biotech sector continue to evolve and grow into the mainstream powerhouse we know it can and will be. We have identified a small Cannabis-Biotech start up that deserves your attention.

InMed Pharmaceuticals (IMLFF) is a Vancouver-based pre-clinical trial Cannabis-Biotech company that has not only developed a proprietary cannabinoid manufacturing system yet in the process created a highly sought after database, which has mapped the different compounds of cannabinoids to the various diseases that it can address.

This cannabinoid database was designed by (IMLFF) to assist them in their investigative studies and has currently become a core asset as other Cannabis Biotech companies have come knocking on their door willing to offer a hefty sum for this information. Most medical marijuana processors are using THC and CBD because they are easy to extract in large quantities, however there are more than 90 diverse cannabinoid structures that (IMLFF) has plugged into its system. The bioinformatics algorithm has taken those different compounds and screens them against approved drugs, diseases and genetic properties of diseases. It then selects specific cannabinoids that might help regulate that particular disease.

InMed Pharmaceuticals (IMLFF) has created this database “tool” & is saving time and money in the drug research process. It has already helped (IMLFF) to identify two treatments for rare diseases. One for a rare children’s skin disease called epidermolysis bullosa (EB) that has no approved treatments and the other for glaucoma. Chief Executive Officer Eric Adams said, “It’s a very devastating disease and we found out in early testing that this set of cannabinoids treat the major symptoms of this disease giving them a tremendous amount of relief, but it may also reverse the disease, which is something no one has really talked about before.”

Startup Cannabis-Biotechs like InMed Pharmaceuticals (IMLFF) will continue to grow as Marijuana Stocks / Sector continues to evolve into mainstream markets.

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements